Globally, women’s health issues have gained significant traction in recent years. This is largely due to discrepancies in disease patterns – including illness, symptoms and response to illnesses – as well as the approach to the treatment of women’s illnesses within the healthcare system, in comparison to men’s healthcare.
Topics: Life Sciences, Biotechnology
In a recently published report, BCC Research examine the organ-on-a-chip market, which is expecting exponential growth over the forecast period 2021-2026:
Topics: Life Sciences, Biotechnology
As the pandemic stubbornly continues to challenge us, biotechnology has nonetheless made enormous strides. DNA sequencing costs have plummeted, while genetic engineering power has exploded. The very race for vaccines has led to new technologies in discovery, screening, and delivery previously undreamt of.
Topics: Life Sciences, Biotechnology
Building better health could be considered a global motto.
Topics: Life Sciences, Biotechnology
What Is DNA Data Storage?
Topics: Life Sciences, Biotechnology
Synthetic biology. Those aren’t two words most people expect to hear next to each other. What does it mean? Why is it important? How does it impact our future?
Topics: Life Sciences, Biotechnology
If you’re at all interested in health, chances are you’ve heard of the gut microbiome. It’s become quite the buzz word, for both individuals and for companies. In recent years it has attracted millions of dollars in federal grants, awards and funding from venture capitalists. And there is ground-breaking work that is being done in this area. Technological advances in next-generation sequencing and data analytics that is being coupled with modern approaches of systems biology and genetic engineering is significantly expanding our knowledge in the microbial populations and how it interacts with human hosts.
Topics: Life Sciences, Biotechnology
Despite great advances in treatments and technology, cancer continues to be the second leading cause of death—worldwide. This makes the market for next generation cancer diagnostics one that is ripe with significant growth potential. A key driving force for industry growth is liquid biopsy-based cancer diagnostics.
Topics: Life Sciences, Biotechnology
